Effect of menopause on cardiovascular disease and its risk factors: A 9-year follow-up study

Climacteric

Volumn 17, Issue 2, 2014, Pages 164-172

  Ramezani Tehrani, F ^a   Behboudi Gandevani, S ^a   Ghanbarian, A ^b   Azizi, F ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular Disease; Menopause; Tehran Lipid And Glucose Study

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; CHOLESTEROL;

ADULT; ARTICLE; BIOCHEMISTRY; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; MENOPAUSE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION; BLOOD; CARDIOVASCULAR DISEASES; COHORT ANALYSIS; IRAN; QUESTIONNAIRE; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; MENOPAUSE; QUESTIONNAIRES; RISK FACTORS;

EID: 84896373888     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2013.828197     Document Type: Article

References (43)

1. Celermajer DS, Chow CK, Marijon E, Anstey NM, Woo KS. Cardiovascular disease in the developing world: prevalences, patterns, and the potential of early disease detection. J Am Coll Cardiol 2012; 60: 1207-16
2. Agrinier N, Cournot M, Dallongeville J, et al. Menopause and modifiable coronary heart disease risk factors: a population based study. Maturitas 2010; 65: 237-43
3. Ebrahimpour P, Fakhrzadeh H, Heshmat R, Ghodsi M, Bandarian F, Larijani B. Metabolic syndrome and menopause: a population-based study. Diabetes Metab Syndrome: Clin Res Rev 2010; 4: 5-9
4. Torng P L, Su T C, Sung FC, et al. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight - the Chin-Shan community cardiovascular cohort study. Atherosclerosis 2002; 161: 409-15 (Pubitemid 34219195)
5. Wen Y, Doyle MC, Cooke T, Feely J. Effect of menopause on low-density lipoprotein oxidation: is oestrogen an important determinant? Maturitas 2000; 34: 233-8 (Pubitemid 30136421)
6. Antonicelli R, Olivieri F, Morichi V, Urbani E, Mais V. Prevention of cardiovascular events in early menopause: a possible role for hormone replacement therapy. Int J Cardiol 2008; 130: 140-6
7. Palmieri D, Perego P, Palombo D. Estrogen receptor activation protects against TNF-α-induced endothelial dysfunction. Angiology 2013 Feb 20. Epub ahead of print
8. He L, Tang X, Li N, et al. Menopause with cardiovascular disease and its risk factors among rural Chinese women in Beijing: a population-based study. Maturitas 2012; 72: 132-8
9. Casiglia E, Tikhonoff V, CaffiS, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens 2008; 26: 1983-92
10. Lukaszewicz R, Lukaszewicz M, Ceremuzy s ki L. Risk factors of atherosclerosis in premenopausal women with a sense of well-being. Apilot study. Kardiol Pol 2006; 64: 573-80
11. Ignarro L J, Balestrieri M L, Napoli C. Nutrition, physical activity, and cardiovascular disease: an update. Cardiovasc Res 2007; 15: 326-40 (Pubitemid 44970442)
12. Kanjilal S, Gregg E W, Cheng Y J, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med 2006; 27: 2348-55 (Pubitemid 44833360)
13. Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of noncommunicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009; 10: 5
14. Azizi F, Rahmani M, Ghanbarian A, et al. Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol. 2003; 18: 311-19 (Pubitemid 36612894)
15. Hosseinpanah F, Rambod M, Reza Ghaffari HR, Azizi F. Predicting isolated postchallenge hyperglycaemia: a new approach; Tehran Lipid and Glucose Study (TLGS). Diabet Med 2006; 23: 982-9
16. Ainsworth B E, Jacobs D R J r, Leon A S. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc 1993; 25: 92-8 (Pubitemid 23027687)
17. Khalili D, Mosavi-Jarrahi A, Eskandari F, et al. Evaluation of cause of deaths ' validity using outcome measures from a prospective, population based cohort study in Tehran, Iran. PLoS One 2012; 7: e31427
18. Standards of Medical Care in Diabetes 2011. Diabetes Care 2011; 34: S11-61
19. Carretero O A, Oparil S. Essential hypertension. I. Definition and etiology. Circulation 2000; 101: 329-35
20. ATP III guidelines at-a-glance quick desk reference. US Department of Health and Human Services, National Institutes of Health, National Heart Lung and Blood Institute, NIH Publication No. 01-3305, 2001
21. Johannes J, Bairey Merz C N. Is cardiovascular disease in women inevitable? Preparing for menopause and beyond. Cardiol Rev 2011; 19: 76
22. Malinauskiene V, Tamosiunas A. Menopause and myocardial infarction risk among employed women in relation to work and family psychosocial factors in Lithuania. Maturitas 2010; 66: 94-8
23. Messa C, Notarnicola M, Russo F. Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells. Scand J Gastroenterol 2005; 40: 1454-61 (Pubitemid 43028208)
24. Mack W J, Slater C C, Xiang M, Shoupe D, Lobo RA, Hodis HN. Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril 2004; 82: 391-7 (Pubitemid 39092040)
25. Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357: 1301-10 (Pubitemid 47481452)
26. Lemieux I, Lamarche B, Couillard C, et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 2001; 161: 2685-92 (Pubitemid 33134844)
27. Sharrett A R, Ballantyne C M, Coady S A, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins AI and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2001; 104: 1108-13 (Pubitemid 32830392)
28. Chen Z, Peto R, Collins R, MacMahon S, Lu J, Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 1991; 303: 276-82
29. Peters HW, Westendorp IC, Hak AE, et al. Menopausal status and risk factors for cardiovascular disease. J Intern Med 1999; 246: 521-8 (Pubitemid 30003172)
30. Poehlman ET, Toth MJ, Ades P A, Rosen CJ. Menopauseassociated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest 2003; 27: 322-6
31. Lovejoy JC. The menopause and obesity. Primary Care-Clinics in Office Practice 2003; 30: 317-26
32. Davis S R, Castelo-Branco C, Chedraui P, et al. Understanding weight gain at menopause. Climacteric 2012; 15: 419-29
33. Panotopoulos G, Raison J, Ruiz C, Guy-Grand B, Basdevant A. Weight gain at the time of menopause. Hum Reprod 1997; 12: 126-33
34. Sternfeld B, Wang H, Quesenberry CP Jr, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women ' s Health Across the Nation. Am J Epidemiol 2004; 160: 912-22 (Pubitemid 39434775)
35. Bailey-Downs LC, Tucsek Z, Toth P, et al. Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. J Gerontol A Biol Sci Med Sci 2013; 68: 780-92
36. Nguyen N T, Magno C P, Lane K T, Hinojosa M W, Lane J S. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 2008; 207: 928-34
37. Feng RN, Zhao C, Wang C, et al. BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in Northern Chinese adults. J Epidemiol 2012; 22: 317-23
38. Cercato C, Mancini M C, Arguello A M, Passos V Q, Villares S M, Halpern A. Systemic hypertension, diabetes mellitus, and dyslipidemia in relation to body mass index: evaluation of a Brazilian population. Rev Hosp Clin Fac Med Sao Paulo 2004; 59: 113-18
39. Osuji C U, Omejua E G, Onwubuya E I, Ahaneku G I. Serum lipid profile of newly diagnosed hypertensive patients in Nnewi, South-East Nigeria. Int J Hypertens 2012; 2012: 710486
40. Brown C D, Higgins M, Donato K A, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2012; 8: 605-19
41. Iughetti L, Predieri B, Bruzzi P, Balli F. Approaches to dyslipidemia treatment in children and adolescents. Expert Rev Endocrinol Metab 2008; 3: 615-33
42. Kuh D, Langenberg C, Hardy R, et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study. BJOG 2005; 112: 476-85 (Pubitemid 40516564)
43. NIH State-of-the-Science Conference on Management of Menopause-Related Symptoms March 21 - 23, 2005. Access date: 5 Feb, 2011. http://consensus.nih. gov/2005/menopauseabstracts.pdf